Amcor plc · AMCR · FY2026 Q4 · Calendar Q3 2026

Amcor maintains transition outlook as synergies run ahead of plan

The current analysis supports a constructive but conditional view: synergy capture and integration benefits are supporting earnings, while working-capital recovery, leverage reduction, volume growth and cost pass-through remain important evidence to monitor.

Reported Before market openNYSEConsumer Cyclical $19.37B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $1.23 Consensus $1.19
EPS surprise +3.4% Reported versus consensus
Reported revenue $6.40B Consensus $6.05B
Revenue surprise +5.7% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move -1.8% Event window
SPY move +0.3% Same window
Abnormal move -2.0% Stock minus SPY
Volume 1.5× Versus trailing sessions
Subsequent drift -7.6% Up to 20 sessions
AMCRSPY benchmark

Ask FN2 about AMCR FY2026 Q4

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Synergy capture reached $285 million for FY2026, including $115 million in Q4, and management identified a $500 million working-capital impact expected to be recovered over the next 12 months. The transition-period outlook was maintained, and the quarterly dividend was raised to $0.65 per share.

Guidance delta

Management maintained guidance for the six-month transition period at adjusted EPS of $1.80-$1.90 and targeted double-digit EPS growth in calendar 2027.

Key takeaways

  • Adjusted EPS rose 23% year over year in Q4 and 13% for FY2026.
  • FY2026 synergy capture reached $285 million, ahead of the original target.
  • Management expects to recover a $500 million working-capital impact over the next 12 months.
  • Leverage was 3.5x, with a target of roughly 3x by year-end 2027.

Management priorities

  • Deliver the $650 million three-year synergy target by 2027
  • Reduce leverage to approximately 3x by year-end 2027
  • Expand higher-margin categories and cross-selling opportunities
  • Invest in innovation and sustainability
  • Maintain dividend growth and an investment-grade balance sheet

Follow AMCR with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
AMCR REVENUE earnings history estimate and actual scatter chart 8 reported fiscal quarters and 4 future estimate-only quarters. Q2 '24 estimate $3B Q2 '24 actual $3B, miss Q3 '24 estimate $3B Q3 '24 actual $3B, miss Q4 '24 estimate $4B Q4 '24 actual $4B, miss Q1 '25 estimate $3B Q1 '25 actual $3B, match Q4 '25 estimate $5B Q4 '25 actual $5B, miss Q1 '26 estimate $6B Q1 '26 actual $6B, miss Q2 '26 estimate $6B Q2 '26 actual $5B, miss Q4 '26 estimate $6B Q4 '26 actual $6B, beat Q1 '27 estimate $6B Q2 '27 estimate $6B Q3 '27 estimate $6B Q4 '27 estimate $6B

Analyst Consensus ?

ConsensusHold14 ratings
Bullish857.1%
Neutral535.7%
Bearish17.2%

Analyst 52W Price Targets

$42.33Current
$43Low
$52.78Average
$82.5High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 21, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
JP Morgan Neutral OverweightDowngradeAug 17, 2026
Wells Fargo Equal Weight Equal WeightMaintainAug 14, 2026
Citigroup Buy BuyMaintainAug 14, 2026
Jefferies Hold BuyDowngradeJul 22, 2026
BMO Capital Market Perform OutperformDowngradeJul 17, 2026
Show 9 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $42.32. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Truist FinancialMichael Roxland$51$46.2 +20.5%Aug 18, 2026
UBSNathan Reilly$56$47.11 +32.3%Aug 11, 2026
JefferiesRamoun Lazar$44.92$43.44 +6.1%Jul 21, 2026
BMO CapitalAnalyst unavailable$47$44.84 +11.0%Jul 16, 2026
Wells FargoAnalyst unavailable$43$42.78 +1.6%Jul 15, 2026
See 14 more

Track every rating change on AMCR the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Amcor plc stands as a prominent global provider of packaging solutions, focusing on the creation, production, and distribution of its diverse product portfolio across Europe, North America, Latin America, Africa, and the Asia Pacific regions. The company's operations are divided into two main segments: Flexibles and Rigid Packaging. The Flexibles division specializes in offering advanced flexible and film packaging solutions, catering to a wide array of industries including food and beverages, medical and pharmaceutical sectors, fresh produce, snack foods, and personal care items.…

Historical context

All AMCR earnings

Consumer Cyclical peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the AMCR recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-08-12T19:15:39.053307+00:00
  2. FN2 earnings calendar · 2026-09-17T01:23:13.296768+00:00
  3. Polygon adjusted daily market bars · 2026-09-21T17:30:54.880110+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-21T17:30:54.876047+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.